Parathyroid carcinoma;Le carcinome parathyroïdien

Bulletin du Cancer

Volumn 93, Issue 3, 2006, Pages 283-287

  Poissonnet, Gilles ^a   Castillo, Laurent ^b   Bozec, Alexandre ^a   Peyrottes, Isabelle ^a   Ettore, Francette ^a   Santini, José ^b   Demard, François ^a   Dassonville, Olivier ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b PASTEUR HOSPITAL   (France)

Author keywords

Hypercalcemia; Parathyroid carcinoma; Primitive hyperparathyroidism; Surgery

Indexed keywords

CALCIUM; PARATHYROID HORMONE; TECHNETIUM 99M;

CANCER CONTROL; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; ECHOGRAPHY; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; IMAGING; METASTASIS; NECK DISSECTION; PARATHYROID CARCINOMA; PREOPERATIVE PERIOD; REVIEW; SCINTIGRAPHY; THYROIDECTOMY; TUMOR LOCALIZATION; GENETICS; PARATHYROID TUMOR;

HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; PARATHYROID NEOPLASMS;

EID: 33645402162     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Demard F, Santini J, Poissonnet G, Dassonville O, Castillo L, Ettore F. Chirurgie des hypoparathyroïdies primaires: nouvelles stratégies. Rev Laryngol Otol Rhinol (Bord) 1997; 117: 203-14.
2. Santini J, Castillo L, Poissonnet G, Demard F. Chirurgie des glandes parathyroïdes. Encycl Med Chir (Elsevier, Paris), Techniques Chirurgicales -Tête et cou], 46-465, 1997.
3. Castillo L, Poissonnet G, Haddad A, Guevara N, Santini J, Demard F. Carcinome parathyroïdien: diagnostic et traitement. Rev Laryngol Otol Rhinol (Bord) 2000; 121: 169-73.
4. Shortell CK, Andrus CH, Phillips Jr. CE, Schwartz SI. Carcinoma of the parathyroid gland: a 30-year experience. Surgery 1991; 110: 704-8.
5. Calender A. L'identification du gène associé à la prédisposition aux néoplasies endocriniennes multiples de type 1 (NEM 1): une nouvelle voie de recherche dans la physiopathogénie des tumeurs neuro-endocrines. Bull Cancer 1997; 84: 993-5.
6. Arnold A. Genetic basis of endocrine disease 5. Molecular genetics of parathyroid gland neoplasia. J Clin Endocrinol Metab 1993; 77: 1108-12.
7. Vasef MA, Brynes RK, Sturm M, Bromley C, Robinson RA. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. Mod Pathol 1999; 12: 412-6.
8. Mittendorf EA, McHenry CR. Parathyroid carcinoma. J Surg Oncol 2005; 89: 136-42.
9. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, et al. Somatic and germ-line mutations of HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003; 349: 1691-2.
10. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 2004; 41: 657-63.
11. Haven CJ, Howell VM, Eilers PH, Dunne R, Takahashi M, Van Puijenbroek M, et al. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res 2004; 64: 7405-11.
12. Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C, et al. Loss of parafibromine immunoreactivity is a distinguish feature of parathyroid carcinoma. Clin Cancer Res 2004; 10: 6629-37.
13. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 2003; 40: 657-63.
14. DeLellis RA. Parathyroid carcinoma: an overview. Adv Anat Pathol 2005; 12: 53-61.
15. Silverberg SJ, Bone 3rd HG, Marriott TB, Locker FG, Thys-Jacobs S, Dziem G, et al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Engl J Med 1991; 337: 1506-10.
16. Stewart AF. Translational implications of the parathyroid calcium receptor. N Engl J Med 2004; 351: 324-6.
17. Wiseman SM, Rigual NR, Hicks WL, Popat SR, Lore JM, Douglas WG, et al. Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat 2004; 83: 491-4.
18. 99-m Sestamibi: Preoperative localization and tissue uptake studies. J Nucl Med 1992; 33: 313-8.
19. Mc Henry CR, Lee K, Saadey J, Esselstyn Jr. CB. Parathyroid localization with technetium-99sestamibi: a prospective evaluation. J Am Coll Surg 1996; 183: 25-30.
20. Al-Sobhi S, Ashari LH, Ingemansson S. Detection of metastatic parathyroid carcinoma with Tc-99sestamibi imaging. Clin Nucl Med 1999; 24: 21-3.
21. Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R. Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer 2004; 100: 900-5.
22. Sandelin K, Thompson NW, Bondeson L. Metastatic parathyroid carcinoma: dilemmas in management. Surgery 1991; 110: 978-88.
23. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience. Head Neck 2004; 26: 716-26.
24. Dotzenrath C, Goretzki PE, Sarbia M, Cupisti K, Feldkamp J, Roher HD. Parathyroid carcinoma: problems in diagnosis and the need for radical surgery even in recurrent disease. Eur J Surg Oncol 2001; 27: 383-9.
25. Koea JB, Shaw JH. Parathyroid cancer: biology and management. Surg Oncol 1999; 8: 155-65.
26. Munson ND, Foote RL, Northcutt RC, Tiegs RD, Fitzpatrick LA, Grant CS. Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer 2003; 98: 2378-84.
27. Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Marx SJ. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab 1998; 83: 1083-8.
28. De Francisco AM. Cinacalcet HCl: a novel therapeutic for hyperparathyroidism. Expert Opin Pharmacother 2005; 6: 441-52.
29. Schantz A, Castelman B. Parathyroid carcinoma. A study of 71 cases. Cancer 1973; 31: 600-5.
30. Lumachi F, Ermani M, Marino F, Poletti A, Basso SM, Iacobone M, et al. Relationship of AgNOR counts and nuclear DNA content to survival in patients with parathyroid carcinoma. Endocr Relat Cancer 2004; 11: 563-9.
31. Kameyama J, Takami H, Umemura S, Osamura YR, Wada N, Sugino K, et al. PCNA and Ki-67 as pronostic markers in human parathyroid carcinomas. Ann Surg Oncol 2000; 7: 301-5.
32. Bergero N, De Pompa R, Sacerdote C, Gasparri G, Volante M, Bussolati G, et al. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol 2005; 36: 908-14.
33. Iacobone M, Ruffolo C, Lumachi F, Favia G. Results of iterative surgery for persistent and recurrent parathyroid carcinoma. Langenbecks Arch Surg 2005; 390: 385-90.